SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-079262
Filing Date
2024-07-11
Accepted
2024-07-11 17:15:21
Documents
16
Period of Report
2024-07-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2419333d1_8k.htm   iXBRL 8-K 28848
2 EXHIBIT 16.1 tm2419333d1_ex16-1.htm EX-16.1 5010
6 GRAPHIC tm2419333d1_ex16-1.jpg GRAPHIC 4049
7 GRAPHIC tm2419333d1_ex16-2.jpg GRAPHIC 5282
  Complete submission text file 0001104659-24-079262.txt   221474

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clrb-20240708.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20240708_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20240708_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2419333d1_8k_htm.xml XML 3568
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 241112674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)